Preparing for New U.S. Biotech Legislation
Companies must adapt as U.S. advances biotech bill restricting Chinese suppliers.
- Latest
- Trending
Companies must adapt as U.S. advances biotech bill restricting Chinese suppliers.
Explore top biotech ETFs like XBI, BBH, and IBB, offering potential returns and portfolio diversification in a growing market.
Kezar halts tumor drug trials, pivots to autoimmune hepatitis focus with promising zetomipzomib.
Jacksonville University's Davis College secures NSA/NSF grant, boosting cybersecurity education on the First Coast.
Moderna & Coursera launch a free course on mRNA tech, transforming STEM education and workforce readiness globally.
Amgen plans a new site in Hyderabad to boost digital capabilities and advance its medicine pipeline.
Amgen taps into India's talent with new Hyderabad innovation site for advancing biotechnology and AI.
AI's role in digital economy poses challenges, particularly for women. Learn how AI affects women's opportunities and roles.
Roivant reports strong clinical progress, with significant Phase 3 study completions, revenue growth, and financial strength.
Bruker sees strong growth in Q2 2024, with strategic acquisitions boosting revenues despite challenges in biopharma and Chinese markets.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.